In Other News

• Pfizer and BioNTech to Jointly Develop COVID-19 Vaccine

• US FDA Authorizes Blood Purification Device to Treat Acute Respiratory Failure in COVID-19 Patients

• Philips Enters into Agreement with US Government to Double Ventilator Production by May

• BardyDx's CAM Patch Chosen for Measuring QT Segments in COVID-19 Patients Using Hydroxychloroquine

• PHASE Scientific Launches RNA Extraction Kit for COVID-19 Test

• COVID-19 Playbook Leverages Advanced Analytics for Accelerating Vaccine Development and Drug Discovery

• PCR Biosystems Ramps Up Production of Critical Enzyme Mix for COVID-19 Tests

• Macromoltek Offers Computational De Novo Antibody Design Targeting COVID-19

• Co-Diagnostics Receives FDA EUA for Logix Smart Coronavirus COVID-19 Test

• Pluristem Reports Preliminary Data from Its COVID-19 Compassionate Use Program

• First Stem Cell Clinical Trial for Protection Against COVID-19 Approved by FDA

• Novavax To Launch First-in-Human Trial of COVID-19 Vaccine in May

• AstraZeneca Begins Research for Discovering Novel Coronavirus-Neutralizing Antibodies

• Bio-Rad Launches Serology Assay for Detection of Coronavirus Antibodies

• Roche Partners with Arrakis in Multi-Billion Dollar Deal to Develop RNA-Targeting Drugs

• Canon Medical Developing Rapid Genetic Testing System for Novel Coronavirus

• Human Testing of Promising Potential Treatment for COVID-19 Begins after FDA Approval

• Takeda Developing Plasma-Derived Therapy for COVID-19

• Artificial Intelligence Platform Helps Find Combination Drug Treatments for COVID-19

• Agfa Offers Chest+ Software for Gridless Bedside Imaging Free to Support Healthcare’s COVID-19 Battle

• Rapid, Portable, Point-of-Care COVID-19 Test Receives USD 13 Million Funding from BARDA

• GSK Collaborates with Vir Biotechnology to Find Coronavirus Solutions

• XBiotech and BioBridge Jointly Developing COVID-19 Treatment Based on Natural Antibodies from Recovered Patients